CY1114183T1 - Κοκκωδης ουσια για τον σχηματισμο δισκιων διασπειρομενων στο στομα - Google Patents

Κοκκωδης ουσια για τον σχηματισμο δισκιων διασπειρομενων στο στομα

Info

Publication number
CY1114183T1
CY1114183T1 CY20131100657T CY131100657T CY1114183T1 CY 1114183 T1 CY1114183 T1 CY 1114183T1 CY 20131100657 T CY20131100657 T CY 20131100657T CY 131100657 T CY131100657 T CY 131100657T CY 1114183 T1 CY1114183 T1 CY 1114183T1
Authority
CY
Cyprus
Prior art keywords
mouth
granular substances
granulate
forming dispersants
dispersants
Prior art date
Application number
CY20131100657T
Other languages
English (en)
Inventor
Massimiliano Rossi
Riccardo Catalano
Silvia Boschetti
Paolo Andreatta
Original Assignee
E-Pharma Trento S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40909993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114183(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by E-Pharma Trento S.P.A. filed Critical E-Pharma Trento S.P.A.
Publication of CY1114183T1 publication Critical patent/CY1114183T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μια κοκκώδη ουσία που περιέχει μαννιτόλη και σορβιτόλη σε μια αναλογία βάρους μεταξύ 70:30 και 97:3. Η εφεύρεση αφορά επίσης τη χρήση της εν λόγω κοκκώδους ουσίας στην παρασκευή διασπειρόμενων στο στόμα δισκίων, τα διασπειρόμενα στο στόμα δισκία που λαμβάνεται με την εν λόγω κοκκώδη ουσία και μια διαδικασία παραγωγής για τη λήψη της εν λόγω κοκκώδους ουσίας.
CY20131100657T 2009-04-09 2013-08-01 Κοκκωδης ουσια για τον σχηματισμο δισκιων διασπειρομενων στο στομα CY1114183T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09425135.2A EP2238974B9 (en) 2009-04-09 2009-04-09 Granulate for the formulation of orodispersible tablets

Publications (1)

Publication Number Publication Date
CY1114183T1 true CY1114183T1 (el) 2016-08-31

Family

ID=40909993

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100657T CY1114183T1 (el) 2009-04-09 2013-08-01 Κοκκωδης ουσια για τον σχηματισμο δισκιων διασπειρομενων στο στομα

Country Status (10)

Country Link
US (3) US20100260854A1 (el)
EP (1) EP2238974B9 (el)
CA (1) CA2697576C (el)
CY (1) CY1114183T1 (el)
DK (1) DK2238974T3 (el)
ES (1) ES2422281T3 (el)
HR (1) HRP20130805T2 (el)
PL (1) PL2238974T3 (el)
PT (1) PT2238974E (el)
SI (1) SI2238974T1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2422281T3 (es) * 2009-04-09 2013-09-10 E Pharma Trento Spa Granulado para la formulación de comprimidos bucodispersables
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
DE19615418A1 (de) * 1996-04-22 1997-10-23 Merck Patent Gmbh Polyol-Zusammensetzung
JP4947833B2 (ja) 1997-07-25 2012-06-06 アルペックス・ファルマ・ソシエテ・アノニム 速崩壊性口内溶解錠の製造に適した顆粒の製造方法
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
FR2787110B1 (fr) * 1998-12-11 2001-02-16 Roquette Freres Sorbitol pulverulent et son procede de preparation
NZ512166A (en) * 2001-06-01 2003-09-26 Marketing Brokers Nz Ltd Wax applicator with a cylindrical roller having convex ends.
ATE346590T1 (de) 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FI20021312A (fi) * 2002-07-03 2004-01-04 Danisco Sweeteners Oy Polyolikoostumusten kiteyttäminen, kiteinen polyolikoostumustuote ja sen käyttö
AU2005271036B2 (en) * 2004-08-12 2009-11-19 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a NSAID and a sugar alcohol made by melt extrusion
FR2894475B1 (fr) 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
US20070212417A1 (en) * 2006-03-07 2007-09-13 Cherukuri S R Compressible resilient granules and formulations prepared therefrom
FR2898492B1 (fr) 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
CN102046147B (zh) * 2007-06-06 2013-03-20 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
ES2422281T3 (es) * 2009-04-09 2013-09-10 E Pharma Trento Spa Granulado para la formulación de comprimidos bucodispersables

Also Published As

Publication number Publication date
CA2697576A1 (en) 2010-10-09
CA2697576C (en) 2017-07-11
EP2238974B9 (en) 2014-05-21
HRP20130805T2 (en) 2013-10-11
US9861581B2 (en) 2018-01-09
US20180092849A1 (en) 2018-04-05
US20160045438A1 (en) 2016-02-18
PT2238974E (pt) 2013-07-09
ES2422281T3 (es) 2013-09-10
US10632073B2 (en) 2020-04-28
EP2238974B1 (en) 2013-06-05
HRP20130805T1 (en) 2013-09-30
DK2238974T3 (da) 2013-08-26
PL2238974T3 (pl) 2013-09-30
US20100260854A1 (en) 2010-10-14
EP2238974A1 (en) 2010-10-13
SI2238974T1 (sl) 2013-09-30

Similar Documents

Publication Publication Date Title
CY1120780T1 (el) Μακροκυκλικοι αναστολεις πρωτεασης σερινης της ηπατιτιδας c
CY1122209T1 (el) Νεα συνθεση με βαση κοκκιου του γ-υδροξυβουτυρικου οξεος
CY1119167T1 (el) Αναστολεις toy nkcc για τη θεραπεια του αυτισμου
CY1115660T1 (el) Επιστρωμενες me υμενα και/ή κοκκωμενες ασβεστουχες ενωσεις και η χρηση τους σε φαρμακευτικες συνθεσεις
CY1122114T1 (el) Καταπινομενα δισκια ν-ακετυλοκυστεϊνης
CY1114190T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
CY1115030T1 (el) Διειδικα αντι-vegf/αντι-ang-2 αντισωματα
BR112013019223A2 (pt) forma de dosagem para liberação modificada, processo para a fabricação de um comprimido e processo para a fabricação de uma forma de dosagem oral
CY1114183T1 (el) Κοκκωδης ουσια για τον σχηματισμο δισκιων διασπειρομενων στο στομα
CY1123022T1 (el) Σταθερες φαρμακευτικες συνθεσεις που περιεχουν σιταγλιπτινη υπο τη μορφη δισκιων αμεσης απελευθερωσης
CU24011B1 (es) Piperidinas 2-fenil-5-(1,2,4-oxadiazol-5-il) sustituidas
CY1109358T1 (el) Εκδοχο για την αναγωγη των ιοντων χρωμιου (vi) σε ιοντα χρωμιου (iii)
CN302079209S (zh) 包装瓶（天天钙咀嚼片）
CN302070578S (zh) 包装瓶（钙咀嚼片）
CN302392043S (zh) 火焰传感器
CN302332322S (zh) 主动发光车道指示标
TR201010112U (tr) Dolum sürgüsü.
CN302323812S (zh) 装饰灯(第六代)
CN302053254S (zh) Led警灯（c4-i4）
CN302470567S (zh) Led封装
CN302079205S (zh) 包装瓶（铁锌钙）
CN302229577S (zh) 包装瓶（钙d叶酸咀嚼片）
CN302323810S (zh) 转向灯(第八代)
CN302346518S (zh) 椅子
CN302362081S (zh) 点验钞机（6900）